Acura Pharmaceuticals, Inc.
ACUR
$0.02
$0.0191,900.00%
| 09/30/2021 | 06/30/2021 | ||||
|---|---|---|---|---|---|
| Revenue | -55.95% | -4.81% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -55.95% | -4.81% | |||
| Cost of Revenue | -1.28% | -3.70% | |||
| Gross Profit | -151.57% | -6.69% | |||
| SG&A Expenses | -20.46% | 35.84% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.27% | 15.57% | |||
| Operating Income | -77.00% | -105.48% | |||
| Income Before Tax | 32.30% | -49.42% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 32.30% | -49.42% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 32.30% | -49.42% | |||
| EBIT | -77.00% | -105.48% | |||
| EBITDA | -81.56% | -120.31% | |||
| EPS Basic | 61.11% | -12.50% | |||
| Normalized Basic EPS | 21.43% | -12.00% | |||
| EPS Diluted | 65.00% | 0.00% | |||
| Normalized Diluted EPS | 21.43% | -12.00% | |||
| Average Basic Shares Outstanding | 76.18% | 32.11% | |||
| Average Diluted Shares Outstanding | 76.18% | 32.11% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
